newsfilter
← Latest News
GlobeNewswire·

Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®

CANTON, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (NASDAQ:ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions